Price competition in the Chinese pharmaceutical market

International Journal of Health Care Finance and Economics

Volumn 6, Issue 2, 2006, Pages 119-129

  Wang, Y Richard ^a,b  

^a ASTRAZENECA   (United Kingdom)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Generic competition; Pharmaceutical market in developing countries; Pharmaceutical price competition; Therapeutic competition

Indexed keywords

ARTICLE; CHEMISTRY; CHINA; DEVELOPING COUNTRY; DRUG INDUSTRY; ECONOMIC ASPECT; ECONOMICS; FEE; HEALTH CARE QUALITY; HUMAN; PHARMACOKINETICS; STANDARD; STATISTICAL MODEL; STATISTICS;

CHEMISTRY, PHARMACEUTICAL; CHINA; DEVELOPING COUNTRIES; DRUG INDUSTRY; ECONOMIC COMPETITION; HUMANS; LINEAR MODELS; PRESCRIPTION FEES; QUALITY OF HEALTH CARE; THERAPEUTIC EQUIVALENCY;

EID: 33745121237     PISSN: 13896563     EISSN: 15736962     Source Type: Journal    
DOI: 10.1007/s10754-006-5558-5     Document Type: Article

References (8)

1. Caves, Richard E., Michael D. Whinston and Mark A. Hurwitz. (1991). Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry. Brookings Papers on Economic Activity: Microeconomics 1991, 1-66.
2. Danzon, Patricia M. and Li-wei Chao. (2000). "Does Regulation Drive out Competition in Pharmaceutical Markets?" Journal of Law and Economics XLIII, 311-357.
3. Danzon, Patricia M., Y. Richard Wang and Liang Wang. (2003). "The Impact of Price Regulation on the Launch Delay of New Drugs: Evidence from Twenty-Five Major Markets in the 1990s." NBER Working Paper No. w9874, July 2003. Available at http://www.nber.org.
4. Frank, Richard G. and David S. Salkever. (1997). "Generic Entry and the Pricing of Pharmaceuticals." Journal of Economics and Management Strategy 6(1), 75-90.
5. Grabowski, Henry G. and John M. Vernon. (1992). "Brand Loyalty, Entry, and Price Competition in Pharmaceuticals After the 1984 drug act." Journal of Law and Economics XXXV, 331-350.
6. IMS Health. (2004). IMS Market Prognosis, Asia 2004-2008. May 2004, London, UK.
7. Kremer, Michael. (2002). "Pharmaceuticals and the Developing World." Journal of Economic Perspectives 16(4), 67-90.
8. Wang, Y. Richard, Lei Ji, and Y. Aileen Lin. (2003). "Intellectual Property Right Protection for Pharmaceuticals in Developing Countries: A Case Study of Administrative Protection in China." Pharmaceutical Development and Regulation 1(4), 277-282.